In addition to its unique mode of action and its activity against otherwise drug-resistant bacteria, the researchers are optimistic about lariocidin because it ticks a lot of the right boxes: it's not toxic to human cells, it's not susceptible to existing mechanisms of antibiotic resistance, and it also works well in an animal model of infection.
You'll probably be reading about these findings in MSM in the coming weeks. Just realize you heard it first on SN, your source for scientific breakthrougs~~
Published in Nature, this is kinda big. Of course, still a long way to go from the lab to the industry, but there are good incentives to speed it up... Bacterial resistance is a bitch.